Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Contact Us

Informazione legale

Newron Pharmaceuticals SpA registered office in Bresso

via L. Ariosto, 21 Bresso (MI) Italy

Company registration number (VAT and Tax Code): 02479490126 (Milan)

Share capital: EUR 1'320'796,60